Vaxcell-Bio Therapeutics Market Cap

Vaxcell-Bio Therapeutics has a market cap or net worth of 212.11 billion as of February 27, 2026. Its market cap has decreased by -7.57% in one year.

Market Cap

212.11B

Enterprise Value

174.06B

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

9,120.00

Market Cap Chart

Since September 22, 2020, Vaxcell-Bio Therapeutics's market cap has increased from 160.24B to 212.11B, an increase of 32.37%. That is a compound annual growth rate of 5.29%.

Market Cap History

Date	Market Cap	% Change
Feb 27, 2026	212.11B	-8.71%
Dec 30, 2025	232.34B	-3.12%
Dec 30, 2024	239.82B	-53.54%
Dec 28, 2023	516.20B	-0.71%
Dec 29, 2022	519.87B	-21.31%
Dec 30, 2021	660.68B	-73.75%
Dec 30, 2020	Upgrade Pro	Upgrade Pro
Sep 22, 2020	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Anterogen.Co.,Ltd.	359.22B
JETEMA,	352.34B
Bioneer	332.95B
Helixmith	295.16B
EASY BIO,Inc.	242.49B
HLB Therapeutics	235.50B
Genexine	198.75B
Macrogen	191.89B

Market Cap Rankings